E5 Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for E5 PHARMA INC, and what generic and branded alternatives to E5 PHARMA INC drugs are available?
E5 PHARMA INC has one approved drug.
Summary for E5 Pharma Inc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for E5 Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E5 Pharma Inc | DIAZOXIDE | diazoxide | SUSPENSION;ORAL | 211050-001 | Dec 20, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
